Business Context and Reporting Period
This Form 8-K filing by iSpecimen Inc. (ISPC) covers the period ending April 29, 2026. The report details the formal filing of a Fifth Amended and Restated Certificate of Incorporation with the State of Delaware to effectuate a reverse stock split and validate a prior corporate action.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes; it does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
- Reverse Stock Split: The Company executed a 1-for-40 reverse stock split, effective April 27, 2026. Trading on a split-adjusted basis began on April 28, 2026.
- Share Count Reduction: Outstanding shares decreased from 52,639,796 immediately prior to the split to approximately 1,316,032 shares following the split.
- Validation of Prior Action: The Board ratified a defective 1-for-20 reverse stock split originally effected on September 13, 2024, via a Certificate of Validation filed on April 29, 2026.
- Equity Adjustments: Proportionate adjustments were made to the exercise prices and share counts for all outstanding stock options, warrants, and restricted stock units.
- Identification Updates: The new CUSIP number for the common stock is 45032V306. The trading symbol remains "ISPC" on the Nasdaq Capital Market.
Guidance, Outlook, and Management Commentary
Management stated the primary objectives of the reverse stock split were to increase the per-share trading price to attract institutional investors and to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The filing does not provide specific financial guidance, risk factors, or contingencies beyond the context of the stock split.
Investor Verification Checklist
- Verify the new CUSIP number (45032V306) for trading and settlement purposes.
- Confirm the adjusted share count and exercise prices for any held options or warrants.
- Monitor the stock price to ensure it meets the Nasdaq minimum bid price requirement post-split.
- Review the Fifth Amended and Restated Certificate of Incorporation (Exhibit 3.1) for any other charter amendments.